Market Place
Sourcing Support
Amneal Pharms’s Generics Isotretinoin Receives Approval in US
07 Oct 2025 //
FDA
SQ Innovation’s Lasix Onyu Receives Approval In US
07 Oct 2025 //
FDA
Boehringer Ingelheim’s Jascayd Receives Approval In US
07 Oct 2025 //
FDA
Taro’s Generics Lamotrigine Receives Approval In US
07 Oct 2025 //
FDA
Lotus’s Generics Nintedanib Receives Tentative Approval In US
06 Oct 2025 //
FDA
Annora`s Generics Mirtazapine Receives Approval in US
02 Oct 2025 //
FDA
Changzhou`s Generics Doxycycline Receives Approval in US
01 Oct 2025 //
FDA
Dr Reddys`s Generics Prednisone Receives Approval in US
01 Oct 2025 //
FDA
Annora`s Generics Bupropion Hydrochloride Receives Approval in US
01 Oct 2025 //
FDA
Eli Lilly`s Inluriyo Receives Approval in US
25 Sep 2025 //
FDA
Crinetics`s Palsonify Receives Approval in US
25 Sep 2025 //
FDA
Stealth Biotherapeutics`s Forzinity Receives Approval in US
19 Sep 2025 //
FDA
Qilu`s Generics Cyclosporine Receives Approval in US
15 Sep 2025 //
FDA
Cipla`s Generics Glucagon Receives Approval in US
15 Sep 2025 //
FDA
Teva`s Generics Macitentan Receives Tentative Approval in US
15 Sep 2025 //
FDA
Xediton Pharma’s Oritiniv Approved in Canada
12 Sep 2025 //
HEALTH CANADA
Hospira`s Generics Potassium Phosphates Receives Approval in US
11 Sep 2025 //
FDA
Macleods`s Generics Potassium Chloride Receives Approval in US
10 Sep 2025 //
FDA
Amneal`s Generics Sodium Oxybate Receives Approval in US
10 Sep 2025 //
FDA
Celltrion’s Biologics Stoboclo Receives Suppl Approval in US
10 Sep 2025 //
FDA
Celltrion’s Biologics Osenvelt Receives Suppl Approval in US
10 Sep 2025 //
FDA
Horizon`s Biologics Tepezza Receives Suppl Approval in US
09 Sep 2025 //
FDA
Aurobindo’s Generics Deferasirox Receives Approval in US
08 Sep 2025 //
FDA
Epic’s Generics Ivermectin Receives Approval in US
08 Sep 2025 //
FDA
Aurobindo’s Generics Prochlorperazine Receives Approval in US
08 Sep 2025 //
FDA
Alembic`s Generics Phytonadione Receives Approval in US
08 Sep 2025 //
FDA
MSN’s Generics Dapagliflozin Receive Tentative Approval in US
05 Sep 2025 //
FDA
Genentech`s Biologics Susvimo Receives Supple Approval in US
05 Sep 2025 //
FDA
Torrent`s Generics Pazopanib HCl Receives Approval in US
04 Sep 2025 //
FDA
Eskayef`s Generics Paliperidone Receives Approval in US
04 Sep 2025 //
FDA
Ajanta`s Generics Topiramate Receives Approval in US
03 Sep 2025 //
FDA
Hopewell`s Generics Sapropterin 2HCl Receives Approval in US
03 Sep 2025 //
FDA
Steriscience`s Generics Ziprasidone Receives Approval in US
03 Sep 2025 //
FDA
Janssen`s Biologics Rybrevant Receives Suppl Approval in US
03 Sep 2025 //
FDA
Abbvie Inc`s Biologics Skyrizi Receives Suppl Approval in US
03 Sep 2025 //
FDA
Nanomi`s Generics Risperidone Receives Approval in US
02 Sep 2025 //
FDA
Amneal`s Generics Risperidone Receives Approval in US
02 Sep 2025 //
FDA
Genzyme`s Wayrilz Receives Approval in US
29 Aug 2025 //
FDA
AbbVie’s Elahere Approved in Canada
29 Aug 2025 //
HEALTH CANADA
Henlius’s Biologics Bilprevda Receives Approval in US
29 Aug 2025 //
FDA
Henlius’s Biologics Bildyos Receives Approval in US
29 Aug 2025 //
FDA
Eisai’s Biologics Leqembi Receives Approval in US
29 Aug 2025 //
FDA
Kyowa Kirin’s Biologics Crysvita Receives Suppl Approval in US
28 Aug 2025 //
FDA
Y-mAbs’s Biologics Danyelza Receives Suppl Approval in US
27 Aug 2025 //
FDA
Teva’s Generics Liraglutide Receives Approval in US
27 Aug 2025 //
FDA
USV’s Generics Sugammadex Receives Tentative Approval in US
27 Aug 2025 //
FDA
Horizon’s Biologics Tepezza Receives Suppl Approval in US
26 Aug 2025 //
FDA
Gilead Sciences`s Yeytuo Receives Approval in Europe
25 Aug 2025 //
EMA
Leo Pharma`s Anzupgo Approved in Canada
25 Aug 2025 //
HEALTH CANADA
Alembic’s Generics Melphalan Gets Tentative Approval in US
25 Aug 2025 //
FDA
Lupin’s Generics Dasatinib Receives FDA Approval in US
25 Aug 2025 //
FDA
Amgen’s Biologics Avsola Recieves Suppl Approval in US
25 Aug 2025 //
FDA
Samsung Bioepis’s Biologics Opuviz Recives Suppl Approval in US
25 Aug 2025 //
FDA
Viatris Pharma`s Nintedanib Viatris Receives Approval in Europe
22 Aug 2025 //
EMA
Ionis`s Pharma`s Dawnzera Receives Approval in US
21 Aug 2025 //
FDA
Sandoz’s Biologics Zarxio Receives Suppl Approval in US
21 Aug 2025 //
FDA
Amgen’s Biologics Repatha Receives Suppl Approval in US
21 Aug 2025 //
FDA
Somerset’s Generics Rilpivirine Receives Tentative Approval in US
20 Aug 2025 //
FDA
King Friend`s Generics Nicardipine HCl Receives Approval in US
20 Aug 2025 //
FDA
Janssen’s Biologics Talvey Receives Suppl Approval in US
19 Aug 2025 //
FDA
